Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure.

Fields AV, Kirkpatrick JN.

Perspect Biol Med. 2012 Winter;55(1):71-80. doi: 10.1353/pbm.2012.0009.

PMID:
22643717
2.

Ethical dilemmas in device treatment for advanced heart failure.

Kirkpatrick JN, Fedson SE, Verdino R.

Curr Opin Support Palliat Care. 2007 Dec;1(4):267-73. doi: 10.1097/SPC.0b013e3282f317a1. Review.

PMID:
18685373
3.

Ethical challenges in advanced heart failure.

Kini V, Kirkpatrick JN.

Curr Opin Support Palliat Care. 2013 Mar;7(1):21-8. doi: 10.1097/SPC.0b013e32835c4915. Review.

PMID:
23328735
4.

Critical appraisal of costly therapy modalities for heart failure in a developing country.

Chemello D, Goldraich L, Alvarez J, Beck-da-Silva L, Clausell N.

Curr Heart Fail Rep. 2013 Dec;10(4):421-6. doi: 10.1007/s11897-013-0159-3. Review.

PMID:
24072512
5.

Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Chamsi-Pasha H, Chamsi-Pasha MA, Albar MA.

Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8. Review.

PMID:
24619521
7.

Device therapy for heart failure.

Boehmer JP.

Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. Review.

PMID:
12670643
8.

Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt JL, Royle P, Bryant J.

Eur Heart J. 2006 Dec;27(24):2929-38. Epub 2006 Apr 7. Review.

PMID:
16603577
9.

REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.

Dembitsky WP.

Semin Cardiothorac Vasc Anesth. 2006 Sep;10(3):253-5.

PMID:
16959761
11.

End-of-life options for patients with advanced heart failure.

Goldfinger JZ, Adler ED.

Curr Heart Fail Rep. 2010 Sep;7(3):140-7. doi: 10.1007/s11897-010-0017-5. Review.

PMID:
20585999
12.

The next treatment option: using ventricular assist devices for heart failure.

Stahovich M, Chillcott S, Dembitsky WP.

Crit Care Nurs Q. 2007 Oct-Dec;30(4):337-46. Review.

PMID:
17873570
13.

Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.

K├╝hne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N, Crawford T, Boonyapisit W, Horwood L, Chugh A, Good E, Jongnarangsin K, Bogun F, Oral H, Morady F, Pagani F, Pelosi F Jr.

Am J Cardiol. 2010 Feb 1;105(3):378-82. doi: 10.1016/j.amjcard.2009.09.044. Epub 2009 Dec 22.

PMID:
20102952
14.

Device therapy in the treatment of heart failure.

Nichols N.

Can J Cardiovasc Nurs. 2006;16(1):28-31. Review. No abstract available.

PMID:
16615262
15.

Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.

Bernard ML, Gold MR.

Heart Fail Clin. 2011 Apr;7(2):241-50, ix. doi: 10.1016/j.hfc.2010.12.007.

PMID:
21439502
16.

Artificial heart and assist devices: directions, needs, costs, societal and ethical issues.

Van Citters RL, Bauer CB, Christopherson LK, Eberhart RC, Eddy DM, Frye RL, Jonsen AR, Keller KH, Levine RJ, McGoon DC, et al.

Artif Organs. 1985 Nov;9(4):375-415.

PMID:
3910005
17.

The financial burden of destination left ventricular assist device therapy: who and when?

Bieniarz MC, Delgado R.

Curr Cardiol Rep. 2007 May;9(3):194-9. Review.

PMID:
17470332
18.

Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.

Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS, Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J, Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P, Higgins R, Mack M.

Ann Thorac Surg. 2012 Dec;94(6):2147-58. doi: 10.1016/j.athoracsur.2012.09.040. Epub 2012 Nov 12. Review.

PMID:
23153481
19.

Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.

Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS, Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J, Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P, Higgins R, Mack M.

Ann Thorac Surg. 2012 Dec;94(6):e163-8. doi: 10.1016/j.athoracsur.2012.09.041. Epub 2012 Nov 12. Review.

PMID:
23153480
20.

Cost-effectiveness of heart failure therapies.

Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA.

Nat Rev Cardiol. 2013 Jun;10(6):338-54. doi: 10.1038/nrcardio.2013.60. Epub 2013 Apr 23. Review.

PMID:
23609174

Supplemental Content

Support Center